{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:57:47Z","timestamp":1793383067262,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtauto.2025.100274","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:35:43Z","timestamp":1737527743000},"page":"100274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The added value of coupling anti-dsDNA and anti-chromatin antibodies in follow-up monitoring of systemic lupus erythematosus patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Caroline","family":"Carl\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Fortenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Bost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Belliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Huart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Alric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Sailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5098-5002","authenticated-orcid":false,"given":"Yves","family":"Renaudineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2025.100274_bib1","first-page":"1","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jtauto.2025.100274_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jtauto.2025.100274_bib3","article-title":"Immunological and translational key challenges in systemic lupus erythematosus: a symposium update","volume":"6","author":"Renaudineau","year":"2023","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2025.100274_bib4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","article-title":"The immunology of systemic lupus erythematosus","volume":"25","author":"Tsokos","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2025.100274_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/08830185.2013.788648","article-title":"B-lymphocyte signalling abnormalities and lupus immunopathology","volume":"32","author":"Taher","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2025.100274_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100274_bib7","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100274_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5152\/TurkArchPediatr.2024.24097","article-title":"Revisiting childhood-onset systemic lupus erythematosus","volume":"59","author":"Avar-Ayd\u0131n","year":"2024","journal-title":"Turk. Arch. Pediatr."},{"key":"10.1016\/j.jtauto.2025.100274_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jalm\/jfab146","article-title":"Anti-dsDNA testing specificity for systemic lupus erythematosus: a systematic review","volume":"7","author":"Orme","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.jtauto.2025.100274_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.140677","article-title":"Four anti-dsDNA antibody assays in relation to systemic lupus erythematosus disease specificity and activity","volume":"42","author":"Enocsson","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100274_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.autrev.2012.07.002","article-title":"Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis","volume":"12","author":"Bizzaro","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100274_bib12","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100274_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100274_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.jtauto.2025.100274_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1191\/096120399680411281","article-title":"Classification and definition of major flares in SLE clinical trials","volume":"8","author":"Petri","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2025.100274_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jtauto.2025.100274_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100274_bib18","article-title":"Urinary soluble CD163 is useful as \u201cliquid biopsy\u201d marker in lupus nephritis at both diagnosis and follow-up to predict impending flares","volume":"9","author":"Renaudineau","year":"2024","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2025.100274_bib19","article-title":"Lupus band test can be used in combination with anti-chromatin antibodies and complement analysis to predict transition from cutaneous to systemic lupus","volume":"234","author":"Carl\u00e9","year":"2022","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2025.100274_bib20","article-title":"Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis, Clin","volume":"229","author":"Bost","year":"2021","journal-title":"Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2025.100274_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/annrheumdis-2016-209489","article-title":"Remission in systemic lupus erythematosus: durable remission is rare","volume":"76","author":"Wilhelm","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2025.100274_bib22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/art.24699","article-title":"A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus","volume":"61","author":"Wallace","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100274_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/rheumatology\/kead231","article-title":"Asia Pacific Lupus Collaboration, SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring","volume":"63","author":"Yeo","year":"2024","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jtauto.2025.100274_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203311411597","article-title":"Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers","volume":"20","author":"Akhter","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2025.100274_bib25","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3411::AID-IMMU3411>3.0.CO;2-G","article-title":"Early anti-nucleosome autoantibodies from a single MRL+\/+ mouse: fine specificity, V gene structure and pathogenicity","volume":"28","author":"Jovelin","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2025.100274_bib26","article-title":"UK jSLE Cohort Study, Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus","volume":"262","author":"Renaudineau","year":"2024","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jtauto.2025.100274_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus \u2013 a proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100274_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1191\/0961203303lu475oa","article-title":"Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients","volume":"12","author":"Ghillani-Dalbin","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2025.100274_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/03009740701218717","article-title":"Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases","volume":"36","author":"Braun","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jtauto.2025.100274_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/keh024","article-title":"Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker","volume":"43","author":"Sim\u00f3n","year":"2004","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jtauto.2025.100274_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.13041","article-title":"Self-dsDNA in the pathogenesis of systemic lupus erythematosus","volume":"191","author":"Bai","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2025.100274_bib32","first-page":"25","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell, Proc. Staff Meet","volume":"23","author":"Hargraves","year":"1948","journal-title":"Mayo Clin."},{"key":"10.1016\/j.jtauto.2025.100274_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1529-0131(200002)43:2<420::AID-ANR24>3.0.CO;2-Z","article-title":"The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera","volume":"43","author":"Schett","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2025.100274_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1568-9972(02)00083-6","article-title":"Anti-chromatin (anti-nucleosome) autoantibodies","volume":"1","author":"Burlingame","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100274_bib35","series-title":"Association of Autoantibody Concentrations and Trajectories with Lupus Nephritis Histologic Features and Treatment Response","author":"Fava","year":"2024"},{"key":"10.1016\/j.jtauto.2025.100274_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0961203308096255","article-title":"Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease","volume":"18","author":"Souza","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2025.100274_bib37","first-page":"316","article-title":"The clinical utility of anti-chromatin antibodies as measured by BioPlex 2200 in the diagnosis of systemic lupus erythematosus versus other rheumatic diseases","volume":"5","author":"Bose","year":"2012","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jtauto.2025.100274_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930802354906","article-title":"BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus","volume":"42","author":"Bardin","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2025.100274_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jtauto.2025.100274_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu","year":"2017","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jtauto.2025.100274_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.jtauto.2025.100274_bib42","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/art.41697","article-title":"A proinflammatory cytokine network profile in Th1\/type 1 effector B cells delineates a common group of patients in four systemic autoimmune diseases","volume":"73","author":"Simon","year":"2021","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.jtauto.2025.100274_bib43","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10238-022-00942-w","article-title":"Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity","volume":"23","author":"Zeng","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jtauto.2025.100274_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:15:12Z","timestamp":1762632912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S2589909025000097"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100274","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The added value of coupling anti-dsDNA and anti-chromatin antibodies in follow-up monitoring of systemic lupus erythematosus patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100274"}}